The Antiinflammatory Mechanism of Igongsan in Mouse Peritoneal Macrophages via Suppression of NF‐κB/Caspase‐1 Activation
2014
Kim, Su‐Jin | Shin, Hyun‐Ji | Lee, Byung‐Joo | Kim, Dae‐Seung | Lee, Jong Hyun | Jeong, Mi‐Young | Kim, Hye‐Lin | Park, Jinbong | Lim, Hara | Kim, Sung‐Hoon | Hong, Seung‐Heon | Hwang, Min‐Woo | Um, Jae‐Young
Igongsan (IGS), which is an herbal prescription composed of five different herbs, Ginseng Radix (root of Panax ginseng, Araliaceae), Atractylodis Rhizoma Alba (rhizome of Atractylodes Macrocephala, Compositae), Poria Sclerotium (sclerotium of Poria cocos, Polyporaceae), Glycyrrhizae Radix et Rhizoma (root and rhizome of Glycyrrhiza uralensis, Leguminosae), and Citri Unshius Pericarpium (Peel of Citrus unshiu, Rutaceae), has been traditionally used in Korea to treat a variety of inflammatory diseases. In this study, we investigated to elucidate the mechanism responsible for IGS's antiinflammatory effect in mouse peritoneal macrophages. The findings demonstrate that IGS inhibited the production of inflammatory cytokine and prostaglandins E₂. IGS inhibited the enhanced levels of cyclooxygenase‐2 and inducible NO synthase caused by lipopolysaccharide (LPS). Additionally, it was shown that the antiinflammatory effect of IGS is through regulating the activation of nuclear factor‐kappa B and caspase‐1 in LPS‐stimulated mouse peritoneal macrophages. These results provide novel insights into the pharmacological actions of IGS as a potential candidate for development of new drugs to treat inflammatory diseases. Discussion and conclusion: These results provide novel insights into the pharmacological actions of IGS as a potential candidate for development of new drugs to treat inflammatory diseases.
显示更多 [+] 显示较少 [-]